Refine by MP, party, committee, province, or result type.

Results 1-10 of 10
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Well, 3 by 5 had no impact on the epidemic. Fewer people were treated than were newly infected during the period of time it was achieved, and only half the number of people got on treatment as were hoped to get on treatment in that 3 by 5 initiative.

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  I can't speak for what's in the minds of our public service or our political representatives. I don't know what it is, but I think you've given us the perspective that it's political. You offered ten political ideas as to why something might have happened. I can say that when I

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  Before this discussion, if I had had a good vaccine candidate, I would have taken it to a GLP/GMP facility and asked them to produce a lot suitable for conducting clinical trials. I would then have gone to the CIHR Canadian HIV trials network with a proposal and had them vet the

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  I would say the money should be spent in Canada. It should be spent on vaccine discovery development. One unmet need is a production facility. It should be spent there. Second, if not there, then it should be used to facilitate academic investigator-driven research on vaccine dev

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  To the first question, no. To the second question, I was not party to the original call for proposals. I understand, through consultation with others at the Canadian Association for HIV Research, that economic sustainability was one of the features of that original call. If I

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  Of course. I appreciated Dr. Engelhardt's presentation very much. I apologize, Madam Chair. I appreciate those difficulties, so I polled the heavies at the Canadian Association for HIV Research, and we have a consensus statement to make. Industrial vaccine production capacity i

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  Thank you, Madam Chairman.

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  I will, and it will be brief.

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  My name is Bill Cameron. I'm a professor of medicine at the University of Ottawa, Ottawa Hospital, and I am speaking as the president of the Canadian Association for HIV Research, which had a large professional and academic interest in the proposal that was nicely described, if n

April 13th, 2010Committee meeting

Dr. Bill Cameron

Health committee  It was actually the Pretoria Street Bridge.

April 13th, 2010Committee meeting

Dr. Bill Cameron